Literature DB >> 26171158

Pro-inflammatory effect of fibrinogen on vascular smooth muscle cells by regulating the expression of PPARα, PPARγ and MMP-9.

Shuyue Wang1, Juntian Liu1, D I Wu1, Xiaoming Pang1, Jingjing Zhao1, Xiaolu Zhang1.   

Abstract

Atherosclerosis is a chronic inflammatory disease in the vessel. As one of the inflammatory markers, fibrinogen has been indicated in formation and progression of atherosclerosis. However, it is completely unclear whether fibrinogen produces a pro-inflammatory effect on vascular smooth muscle cells (VSMCs). The purpose of the present study was to observe the effect of fibrinogen on the expression of peroxisome proliferator-activated receptors-α (PPARα), PPARγ and matrix metalloproteinase-9 (MMP-9) in VSMCs. Rat VSMCs were cultured and fibrinogen was used as a stimulant for PPARα, PPARγ and MMP-9 expression. mRNA expression of PPARα, PPARγ and MMP-9 was identified with the reverse transcription polymerase chain reaction. Protein production of PPARα and PPARγ was examined by western blot analysis and the MMP-9 level in the supernatant of VSMCs was measured with the enzyme-linked immunosorbent assay. The results showed that fibrinogen downregulated mRNA and protein expression of PPARα and PPARγ, and upregulated mRNA and protein generation of MMP-9 in VSMCs in time- and concentration-dependent manners. The maximal inhibition of protein expression of PPARα and PPARγ was 71.8 and 79.9%, respectively. The maximal release of MMP-9 was 4 times over the control. The results suggest that fibrinogen exerts a pro-inflammatory effect on VSMCs through inhibiting the expression of anti-inflammatory cytokine PPARα and PPARγ and stimulating the production of pro-inflammatory cytokine MMP-9. The findings provide new evidence for the pro-inflammatory and pro-atherosclerotic effects of fibrinogen.

Entities:  

Keywords:  MMP-9; PPARα; PPARγ; atherosclerosis; fibrinogen; inflammation; vascular smooth muscle cells

Year:  2015        PMID: 26171158      PMCID: PMC4486936          DOI: 10.3892/br.2015.459

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  35 in total

Review 1.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 2.  Peroxisome proliferator-activated receptors--from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease.

Authors:  M A Bouhlel; B Staels; G Chinetti-Gbaguidi
Journal:  J Intern Med       Date:  2007-11-27       Impact factor: 8.989

3.  Fibrinogen is an independent marker for thoracic aortic atherosclerosis.

Authors:  C Tribouilloy; M Peltier; L Colas; M Senni; O Ganry; J L Rey; J P Lesbre
Journal:  Am J Cardiol       Date:  1998-02-01       Impact factor: 2.778

4.  Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.

Authors:  Edmund A Bermudez; Nader Rifai; Julie Buring; JoAnn E Manson; Paul M Ridker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

5.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 6.  Peroxisome proliferator-activated receptors and inflammation.

Authors:  Leonardo A Moraes; Laura Piqueras; David Bishop-Bailey
Journal:  Pharmacol Ther       Date:  2005-09-15       Impact factor: 12.310

Review 7.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

Review 8.  Peroxisome proliferator-activated receptors and atherosclerosis.

Authors:  Sanja S Soskić; Branislava D Dobutović; Emina M Sudar; Milan M Obradović; Dragana M Nikolić; Bozidarka L Zarić; Srdan D Stojanović; Edita J Stokić; Dimitri P Mikhailidis; Esma R Isenović
Journal:  Angiology       Date:  2011-04-05       Impact factor: 3.619

9.  Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.

Authors:  Fang Guo; Juntian Liu; Chenjing Wang; Na Liu; Peipei Lu
Journal:  Biochem Biophys Res Commun       Date:  2009-10-21       Impact factor: 3.575

10.  Fibrinogen-induced endothelin-1 production from endothelial cells.

Authors:  Utpal Sen; Neetu Tyagi; Phani K Patibandla; William L Dean; Suresh C Tyagi; Andrew M Roberts; David Lominadze
Journal:  Am J Physiol Cell Physiol       Date:  2009-02-04       Impact factor: 4.249

View more
  2 in total

1.  Sivelestat sodium hydrate improves post-traumatic knee osteoarthritis through nuclear factor-κB in a rat model.

Authors:  Xiaofeng Yu; Lijun Zhao; Zhiping Yu; Changzheng Yu; Jianfei Bi; Binglong Sun; Haibo Cong
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

Review 2.  Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets.

Authors:  Yue Gao; Di Li; Jianwen Lin; Aline M Thomas; Jianyu Miao; Dong Chen; Shen Li; Chengyan Chu
Journal:  Front Aging Neurosci       Date:  2022-08-12       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.